Our partner is a late-stage clinical company who is committed to developing novel and transformative medicines to create a better future for people in critical need of new treatment options. Their diversified portfolio is designed to make a significant impact on rare peripheral amyloid and neurodegenerative diseases.

This critical hire provided strategic and operational leadership to ensure clinical trials followed good clinical practices. They were responsible for recruiting, mentoring, and directing internal and external Quality Assurance. In this leadership role, they maintained and expanded working knowledge of applicable FDA, EMA applicable regulations, directives, and guidelines.